NCT04887623 Dynamics of Markers of Infection and Inflammation in Hospitalized Coronavirus Disease 2019 (COVID-19) Patients
| NCT ID | NCT04887623 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital Hradec Kralove |
| Condition | COVID-19 Respiratory Infection |
| Study Type | OBSERVATIONAL |
| Enrollment | 30 participants |
| Start Date | 2021-04-01 |
| Primary Completion | 2025-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 30 participants in total. It began in 2021-04-01 with a primary completion date of 2025-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Patients requiring admission to the hospital due to a moderate and severe COVID-19 infection may differ in their ability to respond to viral infection and to eliminate viral load. Several comorbidities and interventions like antivirotic or antiinflammatory treatment may also modify expected patients response and decrease of viral load. In this observational study, evolution of selected inflammatory markers, indicators of severity of infection and patient characteristics will be followed and recorded in hospitalized patients with COVID-19.
Eligibility Criteria
Inclusion Criteria: * SARS CoV2 positive test within last 14 day * bilateral infiltrates on chest X.ray or CT * need for oxygen to keep pulse oximetry saturation above 92% or other respiratory support measures (HFNO, non-invasive ventilation or invasive ventilation) Exclusion Criteria: * known history of intersticial lung disease * known history of congestive heart failure
Contact & Investigator
Vladimir Palicka, MD, CSc.
STUDY CHAIR
University Hospital Hradec Kralove
Frequently Asked Questions
Who can join the NCT04887623 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 90 Years, studying COVID-19 Respiratory Infection. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04887623 currently recruiting?
Yes, NCT04887623 is actively recruiting participants. Contact the research team at pavel.dostal@fnhk.cz for enrollment information.
Where is the NCT04887623 trial being conducted?
This trial is being conducted at Hradec Králové, Czechia.
Who is sponsoring the NCT04887623 clinical trial?
NCT04887623 is sponsored by University Hospital Hradec Kralove. The principal investigator is Vladimir Palicka, MD, CSc. at University Hospital Hradec Kralove. The trial plans to enroll 30 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.